Dr. Rishi Chadha, MD is a board‑certified gastroenterologist who specializes in preventive gastroenterology, colorectal cancer screening, and minimally invasive endoscopic procedures. He completed his fellowship at Sunrise Health GME in Las Vegas and previously trained in internal medicine at St. Vincent’s Medical Center in Connecticut.
Nonalcoholic Steatohepatitis (NASH) is a variant of fatty liver disease in which excess fat deposition in the liver leads to liver inflammation and cell injury and scarring. It is felt when one takes low alcohol or none. Cirrhosis and liver failure could develop in case of untreated NASH. The early diagnosis and lifestyle change can prevent or reverse the progression of the disease.
Dr. Chadha examines the family and personal medical history, alcohol use, drugs and risk factors and performs a certain physical examination.
The liver enzymes and other blood markers are quantified to ascertain liver functioning and rule out other potential causes of liver damage.
Dr. Chadha relies on verified scoring systems (e.g., NAFLD Fibrosis Score) in estimating the scope of liver scarring.
In rare or ambiguous cases, the liver biopsy has clear grading of inflammation and fibrosis.
Dr. Rishi Chadha, MD is a board‑certified gastroenterologist who specializes in preventive gastroenterology, colorectal cancer screening, and minimally invasive endoscopic procedures. He completed his fellowship at Sunrise Health GME in Las Vegas and previously trained in internal medicine at St. Vincent’s Medical Center in Connecticut.
NASH is a form of liver hepatitis that is caused by alcohol. Fat deposition occurs in the liver and causes inflammation, cell damages, and scarring.
All these risk factors include obesity or weight gain, type 2 diabetes or prediabetes, high cholesterol or triglycerides, metabolic syndrome, premenopausal obesity, PCOS, and some medications (e.g., steroids).
Many people have no symptoms. It also runs the risk of causing fatigue, slight pain in the right upper abdomen, accidental weight loss, or elevated liver enzymes in the blood test.
ICD-10 code of Nonalcoholic Steatohepatitis is K75.81.
In simple fatty liver (NAFL), no damage is caused. NASH is accompanied by inflammation and scarring, which predisposes the risk of cirrhosis development.
Yes—early NASH can be prevented or even reversed through gradual weight reduction (5-10% of body weight), healthy dietary habits, and regular exercise.
Blood tests for liver enzymes, ultrasound or FibroScan to determine fat and stiffness, noninvasive scoring systems, and, infrequently, liver biopsy can identify the diagnosis.
Reduce or avoid sweetened drinks, processed foods, white bread, pastries, refined carbohydrates, and foods containing added sugars and unhealthy fats.
No. Dr. Chadha begins with noninvasive tests. Biopsy is performed only when results are ambiguous or when advanced liver scarring is suspected.
Call GastroDoxs and schedule an appointment with Dr. Rishi Chadha. He will create a tailor-made liver health program.
